LT4/LT3 Combination Therapy Versus LT4 Monotherapy in Patients With Autoimmune Hypothyroidism.
Condition(s):Autoimmune HypothyroidismLast Updated:June 12, 2023Recruiting
Hide Studies Not Open or Pending
Condition(s):Autoimmune HypothyroidismLast Updated:June 12, 2023Recruiting
Condition(s):Non-Alcoholic Fatty Liver Disease; Diabetes Mellitus, Type 2Last Updated:September 14, 2017Terminated
Condition(s):Hypothyroidism Primary; Lipid Disorder; DyslipidemiasLast Updated:February 23, 2024Recruiting
Condition(s):Intraventricular Hemorrhage of PrematurityLast Updated:July 8, 2022Withdrawn
Condition(s):Congenital HypothyroidismLast Updated:July 28, 2023Recruiting
Condition(s):Heart Failure; Subclinical HypothyroidismLast Updated:March 29, 2018Unknown status
Condition(s):Hypothyroidism; Brain TumorLast Updated:June 24, 2013Terminated
Condition(s):Recurrent GoiterLast Updated:July 17, 2009Completed
Condition(s):HypothyroidismLast Updated:February 23, 2024Recruiting
Condition(s):HypothyroidismLast Updated:March 30, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.